Leaderboards/Infectious Encephalopathies and Encephalitis

Infectious Encephalopathies and Encephalitis

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Andrea C. Wong
University of Pennsylvania
2
Tianling Ou
Broad Institute
3
Sofie Bliddal
Hvidovre Hospital
4
Wanchao Yin
Nanjing University of Chinese Medicine
5
Joseph W. Guarnieri
Children's Hospital of Philadelphia
6
Daniel Ayoubkhani
Office for National Statistics
7
Vaughn D. Craddock
University of Kansas Medical Center
8
Shreena Umit Patel
Central and North West London NHS Foundation Trust
9
John I Hogan
Long Island University
10
Daniela P. Reyes-Capó
University of Miami

Rising Stars Papers

1
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19
Pharmacological Research|2024
44 cit.
2
Mitochondrial antioxidants abate SARS-COV-2 pathology in mice
Proceedings of the National Academy of Sciences|2024
33 cit.
3
Employment outcomes of people with Long Covid symptoms: community-based cohort study
European Journal of Public Health|2024
26 cit.
4
Structural insights into ligand recognition, selectivity, and activation of bombesin receptor subtype-3
Cell Reports|2024
6 cit.
5
Structural features of arrestin-mediated GPCR signaling
Medicine in Drug Discovery|2024
6 cit.
6
Structural basis of the cysteinyl leukotriene receptor type 2 activation by LTD4
Proceedings of the National Academy of Sciences|2025
4 cit.
7
Methodologies for Mitochondrial Omic Profiling During Spaceflight
Methods in molecular biology|2024
3 cit.
8
Considerations for epidemiological studies investigating emerging post-acute infection syndromes: Long Covid as a case study
EClinicalMedicine|2026
1 cit.
9
Subclinical Hypothyroidism Is a Risk Factor in Pregnancy, but Does Levothyroxine Improve Outcomes?
Clinical Thyroidology|2024
0 cit.
10
Donor‐derived strongyloidiasis: The beginning of the end?
Transplant Infectious Disease|2024
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Xu Yang
Xuzhou Central Hospital
2
Christoph Schürmann
Goethe University Frankfurt
3
Mateusz Sikora
Jagiellonian University
4
Sathish K.N. Yadav
University of Bristol
5
Ufuk Borucu
University of Bristol
6
Yuan Xue
Changzhou No.2 People's Hospital
7
Maayan Levy
Palo Alto Institute
8
Benjamin Abramoff
Good Shepherd Penn Partners
9
Christoph A. Thaiss
Palo Alto Institute
10
Lior Jankelson
NYU Langone Health

Emerging Leaders Papers

1
Serotonin reduction in post-acute sequelae of viral infection
Cell|2023
361 cit.
2
The enteric nervous system relays psychological stress to intestinal inflammation
Cell|2023
315 cit.
3
β-Hydroxybutyrate suppresses colorectal cancer
Nature|2022
313 cit.
4
A microbiome-dependent gut–brain pathway regulates motivation for exercise
Nature|2022
277 cit.
5
Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries
Cell|2024
65 cit.
6
Explainable SHAP-XGBoost models for in-hospital mortality after myocardial infarction
Cardiovascular Digital Health Journal|2023
36 cit.
7
A subpopulation of lipogenic brown adipocytes drives thermogenic memory
Nature Metabolism|2023
31 cit.
8
The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection
Brain Behavior & Immunity - Health|2022
29 cit.
9
Psychological and Cognitive Functioning Among Patients Receiving Outpatient Rehabilitation for Post-COVID Sequelae: An Observational Study
Archives of Physical Medicine and Rehabilitation|2022
26 cit.
10
Performance of Publicly Available Large Language Models on Internal Medicine Board-style Questions
PLOS Digital Health|2024
24 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Pedro Fernando da Costa Vasconcelos
Universidade do Estado do Pará
2
Brent Griffith
Henry Ford Health System
3
Didier Raoult
Aix-Marseille Université
4
Masashi Mizuguchi
National Rehabilitation Center for Persons with Disabilities
5
Michael S. Zandi
MRC Prion Unit
6
Tsuneo Morishima
Aichi Medical University
7
Vicente Felipo
Centro de Investigacion Principe Felipe
8
Roger F. Butterworth
St. Michael's Hospital
9
David M. Holtzman
Hope Center for Neurological Disorders
10
Dennis D. Spencer
Boston Children's Hospital

Current Senior Leaders Papers

1
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
International Journal of Antimicrobial Agents|2020
5k cit.
2
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
Scientific Reports|2018
3.6k cit.
3
Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix‐Assisted Laser Desorption Ionization Time‐of‐Flight Mass Spectrometry
Clinical Infectious Diseases|2009
1.9k cit.
4
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Science|2009
1.5k cit.
5
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
Radiology|2020
1.5k cit.
6
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
Proceedings of the National Academy of Sciences|2001
1.3k cit.
7
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Neuron|2005
1.3k cit.
8
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans
Annals of Neurology|2005
1.3k cit.
9
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Nature|2017
1.2k cit.
10
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Science Translational Medicine|2011
1.2k cit.

Reagents for Infectious Encephalopathies and Encephalitis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Caveolin-1 (D46G3) Rabbit Monoclonal Antibody (HRP Conjugate)

#12506$465
View Evidence →
Cell Signaling TechnologyEvidence 64

p130 Cas (E1L9G) Rabbit Monoclonal Antibody

#13383$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

eIF4B (1F5) Mouse Monoclonal Antibody

#13088$158,348
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

CIRBP (D1M8D) Rabbit Monoclonal Antibody

#68522$161,351
View Evidence →
Cell Signaling TechnologyEvidence 67

p58IPK (C56E7) Rabbit Monoclonal Antibody

#2940$161,351
View Evidence →
Cell Signaling TechnologyEvidence 65

Myosin IIb (D8H8) Rabbit Monoclonal Antibody

#8824$161,384
View Evidence →